AVAH Filings — Aveanna Healthcare Holdings Inc. - FilingSpy
AVAH
Aveanna Healthcare Holdings Inc.
A one-stop home healthcare provider, Aveanna sends nurses into private homes to care for medically complex children and adults—many ventilator-dependent or needing round-the-clock attention—alongside home health, hospice, and enteral nutrition for seniors. It was created in 2017 when two home-care firms, Epic Health Services and PSA Healthcare, merged. Caregivers often stay with the same families for years, letting medically fragile children grow up at home rather than in hospitals.
Aveanna Healthcare selling stockholders complete 15M-share secondary offering at $11.75/share
Selling stockholders included affiliates of J.H. Whitney Equity Partners VII, LLC and certain current and former directors and officers of the Company.
Show detailsHide details
On August 20, 2026, Aveanna Healthcare entered into an underwriting agreement with selling stockholders and RBC Capital Markets for a secondary offering of 15,000,000 common shares at $11.75 per share.
The underwriter received a 30-day option to purchase up to an additional 2,250,000 shares.
The offering closed on August 24, 2026; the Company did not issue or sell any shares and received no proceeds.
The underwriting agreement is filed as Exhibit 1.1, with a legal opinion from King & Spalding LLP as Exhibit 5.1.
8.01 Other Events · 9.01 Financial Statements and Exhibits
Aveanna director Dr. Erica Schwartz resigns effective immediately to become CDC Director
Dr. Erica Schwartz, a Class III director, resigned from Aveanna Healthcare Holdings Inc.'s Board of Directors on August 5, 2026, effective immediately.
Show detailsHide details
Her resignation was due to her nomination and confirmation as Director of the U.S. Centers for Disease Control and Prevention.
The resignation was not due to any disagreement with the Company on operations, policies, or practices.
Prior to resigning, Dr. Schwartz served as an independent director and Chair of the Clinical Quality Committee.
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Aveanna completes $175.5M cash acquisition of Family First Homecare and raises 2026 guidance
On June 1, 2026, Aveanna's subsidiary Pediatric Services of America, LLC completed the purchase of all membership interests of Family First Holding, LLC for $175.5 million in cash, funded from cash on hand.
Show detailsHide details
Family First Homecare is a multi-state pediatric home care provider with 27 locations across seven states, including Florida, Illinois, Iowa, North Carolina, Pennsylvania, South Dakota, and Texas.
Aveanna updated full-year 2026 revenue guidance to $2.63–$2.65 billion (from $2.56–$2.58 billion) and Adjusted EBITDA guidance to $338–$342 million (from $328–$332 million), solely reflecting Family First's contributions.
The acquisition was announced via a press release on June 2, 2026, and was previously disclosed in a Form 8-K filed on March 12, 2026.
Financial advisors included Edge Healthcare Partners for Aveanna and Baird and J.P. Morgan Securities for Family First; legal counsel included Bass, Berry & Sims and Greenberg Traurig.
8.01 Other Events · 9.01 Financial Statements and Exhibits
Stockholders elected three Class II directors—Rodney D. Windley, Sam Weil, and Steven E. Rodgers—for three-year terms expiring at the 2029 Annual Meeting.
Show detailsHide details
Aveanna Healthcare Holdings Inc. held its 2026 Annual Meeting of Stockholders on May 29, 2026.
The ratification of Ernst & Young LLP as independent auditor for fiscal year ending January 2, 2027 passed with 198,808,170 votes for and 477,379 against.
A non-binding advisory resolution approving named executive officer compensation passed with 160,094,458 votes for and 19,490,871 against.
No other matters were considered or voted upon at the Annual Meeting.
5.07 Submission of Matters to a Vote of Security Holders
Aveanna Healthcare reprices first lien credit facility, cutting interest rate margins by 50 basis points
On May 26, 2026, Aveanna Healthcare LLC entered into the thirteenth amendment to its First Lien Credit Agreement, repricing its senior secured term loans and revolving credit facility.
Show detailsHide details
The repricing reduces applicable interest rate margins by 0.50% (50 basis points) on both the term loans and revolving credit facility.
The outstanding term loans were refinanced with new 2026 Term Loans totaling $1,318,375,000, and the existing $250,000,000 revolving credit facility was refinanced with a new $250,000,000 facility.
The 2026 Term Loans and revolving credit facility bear interest at Term SOFR plus 3.25% per annum or base rate plus 2.25% per annum, with the revolving facility margin subject to leverage-based adjustments.
An additional 0.25% margin reduction is available if the Borrower obtains a credit rating of at least B2 or B from certain rating agencies; the company issued a press release on May 28, 2026 announcing the repricing.
The event was reported under Item 8.01 (Other Events) as a material debt transaction not otherwise required to be reported.
8.01 Other Events · 9.01 Financial Statements and Exhibits
8-K
Aveanna Healthcare files 8-K furnishing May 2026 investor presentation with 2026 guidance.
On May 15, 2026, Aveanna Healthcare Holdings Inc. furnished an investor presentation as Exhibit 99.1 under Item 7.01 Regulation FD Disclosure.
Show detailsHide details
The presentation includes 2026 guidance: revenue of $2.56B-$2.58B, gross margin of 31.7%, and Adjusted EBITDA of $328M-$332M.
Q1 2026 revenue was $647.9M, up 15.9% year-over-year, with gross margin of $205.4M, up 11.9%.
Operating cash flow for Q1 2026 was positive $4.3M, a $12.9M improvement from Q1 2025.
The information is furnished, not filed, and not incorporated by reference into other SEC filings.
7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits